ClinicalTrials.gg
Enrolling by invitationNCT07065916Updated May 1, 2026

Arm More + Camp: An Implementation Study

An interventional study of Modified Constraint Induced Movement Therapy in Hemiplegia, Cerebral Palsy Spastic Hemiplegic and Acquired Brain Injury (Including Stroke), sponsored by University of Calgary. Enrolling by invitation at 1 site in Canada. Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Calgary · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
5 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Hemiplegia with a site in Canada — 2 open to participants now, 2 under way, none of them phase 3. Hemiplegia · Canada.

Started
2025
the only one that year
No phase
9 of 10
1 open now
Registered
10th of 10
by date
Lead sponsor
2 of 10
University of Calgary

Among the 10 studies in Hemiplegia with a site in Canada, this one is the only one that started in 2025, is one of 9 with no phase, and was the 10th registered.

Hemiplegia

450 studies on the registry are indexed under Hemiplegia; 92 are open to participants now.

Browse Hemiplegia studies →

Open to participants now

2 of the 10 studies in Hemiplegia with a site in Canada are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 59 Hemiplegia studies recruiting now, 16 (27%) set no upper age limit and 31 (53%) stop at 75 or younger; 9 take children under 18; 7 take healthy volunteers.

This study: 5 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Hemiplegia with a site in Canada, or all of them as a file.
02

Study summary

Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis.

Participants will complete a day camp (9am to 4pm) with constraint induced movement therapy in Week 1 and bimanual therapy in Week 2.

03

Conditions studied

  • Hemiplegia
  • Cerebral Palsy Spastic Hemiplegic
  • Acquired Brain Injury (Including Stroke)

Keywords

  • Cerebral palsy
  • Constraint induced movement therapy
  • Bimanual therapy
  • Hemiplegia
04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mild to moderate hemiparesis due to cerebral palsy or acquired brain injury (e.g, traumatic brain injury, stroke)
  • Ability to actively extend wrist to neutral and actively flex and extend fingers (at minimum)
  • Attend school full-time
  • Able to participate in group activities
  • Written consent

Exclusion criteria

Exclusion Criteria:

  • Severe hemiparesis due to cerebral palsy or acquired brain injury
  • No wrist movement on the hemiplegic hand.
  • Unable to concentrate for periods of 60-90minutes
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Modified Constraint Induced Movement Therapy

    Constraint Induced Movement Therapy and Bimanual Therapy

    Behavioral: Modified Constraint Induced Movement Therapy

Interventions

  • BehavioralModified Constraint Induced Movement Therapy

    Constraint Induced Movement Therapy and Bimanual Therapy

06

What researchers measure

Primary outcomes

  1. Implementation Cost

    Implementation cost covers all resources necessary, including personnel, time, space, and supplies.

    Time frame: From enrolment to the end of outcome data collection at 3 weeks

Secondary outcomes

  1. Canadian Occupational Performance Measure

    Time frame: Baseline and the end of treatment at 2 weeks

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Aug 2026, 13 months after the start.

Of 226 non-industry interventional studies with no phase under Hemiplegia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 13 months is close to that.

Counting every sponsor, half of 231 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2025
First posted
Jul 15, 2025
StartActual
Jul 9, 2025
Primary completionEst.
Aug 31, 2026
CompletionEst.
Dec 31, 2026
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07065916
Responsible party
Adam Kirton (Pediatric Neurologist, University of Calgary) — Principal investigator
First posted
Jul 15, 2025
Start date
Jul 9, 2025
Primary completion
Aug 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion